| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |